By performing immune lipoplex nanoparticle biochip assay, Li et al. validated that circulating exosomes GPC1 could serve as a viable biomarker for PC which was validated in clinical cohorts at multiple hospitals [116]. The gene discussed is GPC1; the disease is pachyonychia congenita.